Pneumonia Market, Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: PE7969F657BEEN
Market Monitor Global

Abstracts

Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year. The global pneumonia therapeutics market is projected to expand at a significant pace during the forecast period, due to increase in the number of cases of pneumonia and advancement in treatments. Moreover, growing awareness about pneumonia treatment among patients, rising demand for treatment, increasing incidence of pneumonia, and improvement in diagnosis methods are promoting the growth of the global pneumonia therapeutics market.

This report contains market size and forecasts of Pneumonia in Global, including the following market information:

Global Pneumonia Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Pneumonia market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pneumonia include Pfizer, GlaxoSmithKline(GSK), Merck, Novartis, Sanofi and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pneumonia companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pneumonia Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Pneumonia Market Segment Percentages, by Type, 2021 (%)

• Drugs
• Vaccines
• Oxygen Therapy

Global Pneumonia Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Pneumonia Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgical Centers
• Others

Global Pneumonia Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Pneumonia Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pneumonia revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Pneumonia revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• GlaxoSmithKline(GSK)
• Merck
• Novartis
• Sanofi
• Eli Lilly

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pneumonia Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pneumonia Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PNEUMONIA OVERALL MARKET SIZE

2.1 Global Pneumonia Market Size: 2021 VS 2028
2.2 Global Pneumonia Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Pneumonia Players in Global Market
3.2 Top Global Pneumonia Companies Ranked by Revenue
3.3 Global Pneumonia Revenue by Companies
3.4 Top 3 and Top 5 Pneumonia Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pneumonia Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pneumonia Players in Global Market
  3.6.1 List of Global Tier 1 Pneumonia Companies
  3.6.2 List of Global Tier 2 and Tier 3 Pneumonia Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Pneumonia Market Size Markets, 2021 & 2028
  4.1.2 Drugs
  4.1.3 Vaccines
  4.1.4 Oxygen Therapy
4.2 By Type - Global Pneumonia Revenue & Forecasts
  4.2.1 By Type - Global Pneumonia Revenue, 2017-2022
  4.2.2 By Type - Global Pneumonia Revenue, 2023-2028
  4.2.3 By Type - Global Pneumonia Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pneumonia Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Centers
  5.1.4 Others
5.2 By Application - Global Pneumonia Revenue & Forecasts
  5.2.1 By Application - Global Pneumonia Revenue, 2017-2022
  5.2.2 By Application - Global Pneumonia Revenue, 2023-2028
  5.2.3 By Application - Global Pneumonia Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Pneumonia Market Size, 2021 & 2028
6.2 By Region - Global Pneumonia Revenue & Forecasts
  6.2.1 By Region - Global Pneumonia Revenue, 2017-2022
  6.2.2 By Region - Global Pneumonia Revenue, 2023-2028
  6.2.3 By Region - Global Pneumonia Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Pneumonia Revenue, 2017-2028
  6.3.2 US Pneumonia Market Size, 2017-2028
  6.3.3 Canada Pneumonia Market Size, 2017-2028
  6.3.4 Mexico Pneumonia Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Pneumonia Revenue, 2017-2028
  6.4.2 Germany Pneumonia Market Size, 2017-2028
  6.4.3 France Pneumonia Market Size, 2017-2028
  6.4.4 U.K. Pneumonia Market Size, 2017-2028
  6.4.5 Italy Pneumonia Market Size, 2017-2028
  6.4.6 Russia Pneumonia Market Size, 2017-2028
  6.4.7 Nordic Countries Pneumonia Market Size, 2017-2028
  6.4.8 Benelux Pneumonia Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Pneumonia Revenue, 2017-2028
  6.5.2 China Pneumonia Market Size, 2017-2028
  6.5.3 Japan Pneumonia Market Size, 2017-2028
  6.5.4 South Korea Pneumonia Market Size, 2017-2028
  6.5.5 Southeast Asia Pneumonia Market Size, 2017-2028
  6.5.6 India Pneumonia Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Pneumonia Revenue, 2017-2028
  6.6.2 Brazil Pneumonia Market Size, 2017-2028
  6.6.3 Argentina Pneumonia Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Pneumonia Revenue, 2017-2028
  6.7.2 Turkey Pneumonia Market Size, 2017-2028
  6.7.3 Israel Pneumonia Market Size, 2017-2028
  6.7.4 Saudi Arabia Pneumonia Market Size, 2017-2028
  6.7.5 UAE Pneumonia Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Pneumonia Major Product Offerings
  7.1.4 Pfizer Pneumonia Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 GlaxoSmithKline(GSK)
  7.2.1 GlaxoSmithKline(GSK) Corporate Summary
  7.2.2 GlaxoSmithKline(GSK) Business Overview
  7.2.3 GlaxoSmithKline(GSK) Pneumonia Major Product Offerings
  7.2.4 GlaxoSmithKline(GSK) Pneumonia Revenue in Global Market (2017-2022)
  7.2.5 GlaxoSmithKline(GSK) Key News
7.3 Merck
  7.3.1 Merck Corporate Summary
  7.3.2 Merck Business Overview
  7.3.3 Merck Pneumonia Major Product Offerings
  7.3.4 Merck Pneumonia Revenue in Global Market (2017-2022)
  7.3.5 Merck Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Pneumonia Major Product Offerings
  7.4.4 Novartis Pneumonia Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi Pneumonia Major Product Offerings
  7.5.4 Sanofi Pneumonia Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Key News
7.6 Eli Lilly
  7.6.1 Eli Lilly Corporate Summary
  7.6.2 Eli Lilly Business Overview
  7.6.3 Eli Lilly Pneumonia Major Product Offerings
  7.6.4 Eli Lilly Pneumonia Revenue in Global Market (2017-2022)
  7.6.5 Eli Lilly Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Pneumonia Market Opportunities & Trends in Global Market
Table 2. Pneumonia Market Drivers in Global Market
Table 3. Pneumonia Market Restraints in Global Market
Table 4. Key Players of Pneumonia in Global Market
Table 5. Top Pneumonia Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pneumonia Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pneumonia Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pneumonia Product Type
Table 9. List of Global Tier 1 Pneumonia Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pneumonia Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pneumonia Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pneumonia Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pneumonia Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pneumonia Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pneumonia Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pneumonia Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pneumonia Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pneumonia Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pneumonia Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pneumonia Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pneumonia Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pneumonia Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pneumonia Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pneumonia Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pneumonia Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pneumonia Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pneumonia Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pneumonia Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pneumonia Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Pneumonia Product Offerings
Table 32. Pfizer Pneumonia Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline(GSK) Corporate Summary
Table 34. GlaxoSmithKline(GSK) Pneumonia Product Offerings
Table 35. GlaxoSmithKline(GSK) Pneumonia Revenue (US$, Mn), (2017-2022)
Table 36. Merck Corporate Summary
Table 37. Merck Pneumonia Product Offerings
Table 38. Merck Pneumonia Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Pneumonia Product Offerings
Table 41. Novartis Pneumonia Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Pneumonia Product Offerings
Table 44. Sanofi Pneumonia Revenue (US$, Mn), (2017-2022)
Table 45. Eli Lilly Corporate Summary
Table 46. Eli Lilly Pneumonia Product Offerings
Table 47. Eli Lilly Pneumonia Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Pneumonia Segment by Type in 2021
Figure 2. Pneumonia Segment by Application in 2021
Figure 3. Global Pneumonia Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pneumonia Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pneumonia Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pneumonia Revenue in 2021
Figure 8. By Type - Global Pneumonia Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pneumonia Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pneumonia Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pneumonia Revenue Market Share, 2017-2028
Figure 12. US Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pneumonia Revenue Market Share, 2017-2028
Figure 16. Germany Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 17. France Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pneumonia Revenue Market Share, 2017-2028
Figure 24. China Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 28. India Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pneumonia Revenue Market Share, 2017-2028
Figure 30. Brazil Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pneumonia Revenue Market Share, 2017-2028
Figure 33. Turkey Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Pneumonia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline(GSK) Pneumonia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck Pneumonia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Pneumonia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Pneumonia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Eli Lilly Pneumonia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)